BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 18487207)

  • 1. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3.
    Tao GZ; Lehwald N; Jang KY; Baek J; Xu B; Omary MB; Sylvester KG
    J Biol Chem; 2013 Jun; 288(24):17214-24. PubMed ID: 23620592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II mediates cell survival through upregulation and activation of the serum and glucocorticoid inducible kinase 1.
    Baskin R; Sayeski PP
    Cell Signal; 2012 Feb; 24(2):435-442. PubMed ID: 21963429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.
    Mori S; Nada S; Kimura H; Tajima S; Takahashi Y; Kitamura A; Oneyama C; Okada M
    PLoS One; 2014; 9(2):e88891. PubMed ID: 24558442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer.
    Ordóñez-Morán P; Irmisch A; Barbáchano A; Chicote I; Tenbaum S; Landolfi S; Tabernero J; Huelsken J; Muñoz A; Pálmer HG
    Oncogene; 2014 Apr; 33(15):1975-85. PubMed ID: 23624922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.
    Srivastava M; Leighton X; Starr J; Eidelman O; Pollard HB
    Biomed Res Int; 2014; 2014():193635. PubMed ID: 24864229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components.
    Li L; Ji SY; Yang JL; Li XX; Zhang J; Zhang Y; Hu ZY; Liu YX
    Mol Cell Endocrinol; 2014 Feb; 382(2):915-25. PubMed ID: 24246780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
    Wu W; Zou M; Brickley DR; Pew T; Conzen SD
    Mol Endocrinol; 2006 Oct; 20(10):2304-14. PubMed ID: 16690749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes.
    Wallace K; Long Q; Fairhall EA; Charlton KA; Wright MC
    J Cell Sci; 2011 Feb; 124(Pt 3):405-13. PubMed ID: 21224398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
    Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
    PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
    Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
    Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
    Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
    Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SGK1 mediates the hypotonic protective effect against H
    Chen BY; Huang CC; Lv XF; Zheng HQ; Zhang YJ; Sun L; Wang GL; Ma MM; Guan YY
    Acta Pharmacol Sin; 2020 Aug; 41(8):1073-1084. PubMed ID: 32139897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.
    Ceballos MP; Parody JP; Quiroga AD; Casella ML; Francés DE; Larocca MC; Carnovale CE; Alvarez Mde L; Carrillo MC
    J Interferon Cytokine Res; 2014 Nov; 34(11):858-69. PubMed ID: 24950290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
    Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
    J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGK1-dependent intestinal tumor growth in APC-deficient mice.
    Wang K; Gu S; Nasir O; Föller M; Ackermann TF; Klingel K; Kandolf R; Kuhl D; Stournaras C; Lang F
    Cell Physiol Biochem; 2010; 25(2-3):271-8. PubMed ID: 20110688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell survival kinase SGK1 and its targets FOXO3a and NDRG1 in aged human brain.
    Sahin P; McCaig C; Jeevahan J; Murray JT; Hainsworth AH
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):623-33. PubMed ID: 23363009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
    Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
    J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.